California Joins a New Jersey Company to Make Generic Opioid Overdose Reversal Drug

California Joins a New Jersey Company to Make Generic Opioid Overdose Reversal Drug
Naloxone, known by the commercial name Narcan, reverses the effects of opioid overdoses. Scott Olson/Getty Images
The Associated Press
Updated:
0:00

SACRAMENTO, Calif.—California will soon begin selling its own generic version of Narcan—the drug that can save someone’s life during an opioid overdose—under a deal announced April 29 by Democratic Gov. Gavin Newsom as part of his effort to offer less expensive, state-branded options of medication.

The New Jersey-based Amneal Pharmaceuticals will sell naloxone to California for $24 per pack, or about 40 percent cheaper than the market rate. California plans to give away many of the packs for free to first responders, universities and community organizations through the state’s Naloxone Distribution Project.